1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow SLE: new trials by email Literature Review of SLE trials Research Report on SLE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus Envudeucitinib, Placebo - SLE | Phase 2 | Active not recruiting | Alumis Inc | 408 | 2023-06-26 | 2026-07-21 |
Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Lupus Erythematosus, Systemic (1)
Skin and Connective Tissue Diseases (1)
Alumis Inc (1)
Argentina (1) · Bulgaria (1) · Chile (1) · Colombia (1) · Croatia (1) · Denmark (1) · Georgia (1) · Germany (1) · Hungary (1) · India (1) · Mexico (1) · Peru (1) · Philippines (1) · Poland (1) · Puerto Rico (1)